HK1237283B - 癌症治疗 - Google Patents

癌症治疗 Download PDF

Info

Publication number
HK1237283B
HK1237283B HK17111495.8A HK17111495A HK1237283B HK 1237283 B HK1237283 B HK 1237283B HK 17111495 A HK17111495 A HK 17111495A HK 1237283 B HK1237283 B HK 1237283B
Authority
HK
Hong Kong
Prior art keywords
cancer
nuc
treatment
patient
cycles
Prior art date
Application number
HK17111495.8A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1237283A1 (zh
Inventor
Hugh GRIFFITH
Chris Mcguigan
Chris Pepper
Original Assignee
NuCana plc
Filing date
Publication date
Application filed by NuCana plc filed Critical NuCana plc
Publication of HK1237283A1 publication Critical patent/HK1237283A1/zh
Publication of HK1237283B publication Critical patent/HK1237283B/zh

Links

HK17111495.8A 2015-05-14 癌症治疗 HK1237283B (zh)

Publications (2)

Publication Number Publication Date
HK1237283A1 HK1237283A1 (zh) 2018-04-13
HK1237283B true HK1237283B (zh) 2019-11-29

Family

ID=

Similar Documents

Publication Publication Date Title
US20230226092A1 (en) Cancer treatments based on gemcitabine prodrugs
US20230218655A1 (en) Cancer treatments
CN117881396A (zh) 用螺甾内酯和酰基富烯的组合治疗癌症
HK1261423A1 (zh) 癌症治疗
HK1237283B (zh) 癌症治疗
HK1237283A1 (zh) 癌症治疗
JP6810763B2 (ja) がん治療
TW202029961A (zh) Ar拮抗劑聯合parp抑制劑在製備治療前列腺癌的藥物中的用途
EA040796B1 (ru) Лечение рака